1-13 of 13
Julia Krzykalla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1 -Mutated Acute Myeloid Leukemia

Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W.M. Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammad Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Lars Bullinger, Felicitas R. Thol, Michael Heuser, Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser
Journal: Blood
Blood (2022) 140 (Supplement 1): 2010–2013.
https://doi.org/10.1182/blood-2022-166084
Published: 2022
Journal Articles

Midostaurin Plus Intensive Chemotherapy for Younger and Older Patients with Acute Myeloid Leukemia and FLT3 Internal Tandem Duplications

Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Gerald Wulf, Helmut R. Salih, Michael Lübbert, Michael W.M. Kühn, Thomas Schroeder, Hans Salwender, Katharina S. Götze, Jörg Westermann, Lars Fransecky, Karin Mayer, Bernd Hertenstein, Mark Ringhoffer, Hans-Joachim Tischler, Sigrid Machherndl-Spandl, Anika Schrade, Peter Paschka, Verena I Gaidzik, Frauke Theis, Felicitas R Thol, Michael Heuser, Richard F. Schlenk, Lars Bullinger, Maral Saadati, Axel Benner, Konstanze Döhner, Arnold Ganser
Journal: Blood
Blood (2021) 138 (Supplement 1): 692.
https://doi.org/10.1182/blood-2021-147256
Published: 2021
Journal Articles

Impact of Gender on Molecular AML Subclasses - a Harmony Alliance Study

Tommaso Matteuzzi, Daniele Dall'Olio, Eric Sträng, Alessandra Merlotti, Javier Martinez Elicegui, Axel Benner, Maral Saadati, Julia Krzykalla, Caroline A. Heckman, Ana Heredia Casanoves, Jurjen Versluis, María Abáigar, Alberto Hernandez-Sanchez, Laura Jamilis, Peter JM Valk, Klaus H. Metzeler, Rosa Ayala, Joaquin Martinez Lopez, Herve Dombret, Pau Montesinos, Jorge Sierra, Claude Preudomme, Frederick Damm, Ken I Mills, Raúl Azibeiro Melchor, Jiří Mayer, Christian Thiede, Maria Teresa Voso, Sergio Amadori, Guillermo Sanz, Frederico Calado, Konstanze Döhner, Verena I Gaidzik, Michael Heuser, Torsten Haferlach, Marta Sobas, Amin T. Turki, Dirk Reinhardt, Rubén Villoria Medina, Michel van Speybroeck, Renate Schulze-Rath, Jesús M Hernández Rivas, Brian J.P Huntly, Hartmut Döhner, Gert J. Ossenkoppele, Castellani Gastone, Lars Bullinger
Journal: Blood
Blood (2021) 138 (Supplement 1): 3438.
https://doi.org/10.1182/blood-2021-152215
Published: 2021
Journal Articles

Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1 -mutated AML: results from the AMLSG 09-09 trial

Clinical Trials & Observations
Silke Kapp-Schwoerer, Daniela Weber, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Jan Krönke, Frauke Theis, Frank G. Rücker, Maria-Veronica Teleanu, Ekaterina Panina, Nikolaus Jahn, Julia Herzig, Lena Kubanek, Anika Schrade, Gudrun Göhring, Walter Fiedler, Thomas Kindler, Thomas Schroeder, Karin T. Mayer, Michael Lübbert, Mohammed Wattad, Katharina S. Götze, Heinz A. Horst, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Martin Bentz, Jürgen Krauter, Lars Bullinger, Julia Krzykalla, Axel Benner, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2020) 136 (26): 3041–3050.
https://doi.org/10.1182/blood.2020005998
Published: 2020
Includes: Supplemental data
Journal Articles

Multiplatform Profiling Characterizes Functional Networks in Genomically Stable and Instable Chronic Lymphocytic Leukemia

Johannes Bloehdorn, MD, Andrejs Braun, PhD, Billy Michael Chelliah Jebaraj, PhD, Amaro Taylor-Weiner, PhD, Sandra Robrecht, PhD, Julia Krzykalla, PhD, Karlheinz Holzmann, PhD, Harvey Johnston, PhD, Tetyana Klymenko, PhD, Barbara Eichhorst, MD, Ru-Fang Yeh, PhD, Martin Weisser, MD, Jennifer Edelmann, MDPhD, Kirsten Fischer, MD, John G. Gribben, MD DSc, FRCP, FRCPath, FMedSci, Dan A. Landau, MD PhD, Donna S. Neuberg, ScD, Mark S Cragg, PhD, Axel Benner, Michael Hallek, MD, Catherine J. Wu, MD, Hartmut Döhner, Stephan Stilgenbauer, MD, Daniel Mertens, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-141552
Published: 2020
Journal Articles

Higher Dose of CPX-351 Is Associated with Prolonged Hematologic Recovery: Results from an Interim Safety Analysis of the Randomized, Phase III AMLSG 30-18 Trial

Verena I Gaidzik, MD, Verena Mayr-Benedikter, Daniela Weber, MSc, Anika Schrade, PhD, Jürgen Krauter, Juliane S. Walz, MD, Holger Hebart, MD, Beate S. Schultheis, MD, Nadezda Basara, MD, Elisabeth Dietl, MD, Silke Kapp-Schwoerer, MD, Michaela Feuring-Buske, MD, Felicitas Thol, Michael Heuser, Stefan Faderl, MD, Anthony J. Wagner, Maral Saadati, Julia Krzykalla, PhD, Axel Benner, Arnold Ganser, Konstanze Döhner, Peter Paschka, MD, Hartmut Döhner
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138738
Published: 2020
Journal Articles

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3 -ITD

Clinical Trials & Observations
Richard F. Schlenk, Daniela Weber, Walter Fiedler, Helmut R. Salih, Gerald Wulf, Hans Salwender, Thomas Schroeder, Thomas Kindler, Michael Lübbert, Dominik Wolf, Jörg Westermann, Doris Kraemer, Katharina S. Götze, Heinz-August Horst, Jürgen Krauter, Michael Girschikofsky, Mark Ringhoffer, Thomas Südhoff, Gerhard Held, Hans-Günter Derigs, Roland Schroers, Richard Greil, Martin Grießhammer, Elisabeth Lange, Alexander Burchardt, Uwe Martens, Bernd Hertenstein, Lore Marretta, Michael Heuser, Felicitas Thol, Verena I. Gaidzik, Wolfgang Herr, Julia Krzykalla, Axel Benner, Konstanze Döhner, Arnold Ganser, Peter Paschka, Hartmut Döhner
Journal: Blood
Blood (2019) 133 (8): 840–851.
https://doi.org/10.1182/blood-2018-08-869453
Published: 2019
Includes: Supplemental data
Journal Articles

Prognostic Impact of Insertion Site in Acute Myeloid Leukemia (AML) with FLT3 Internal Tandem Duplication: Results from the Ratify Study (Alliance 10603)

Frank G. Rücker, MD, Ling Du, PhD, Tamara J. Blätte, MSc, Axel Benner, Julia Krzykalla, MSc, Insa Gathmann, Richard A. Larson, MD, Francesco Lo-Coco, MD, Sergio Amadori, MD, Thomas W Prior, MD, Joseph M. Brandwein, MD, Frederick R. Appelbaum, MD, Bruno C. Medeiros, MD, Martin S. Tallman, MD, Michelle Geddes, MD, Jorge Sierra, MD, Eva Tiecke, PhD, Celine Pallaud, PhD, Miguel A. Sanz, MD, Theo M de Witte, MD, Dietger Niederwieser, MD, Gerhard Ehninger, MD, Michael Heuser, MD, Arnold Ganser, MD, Lars Bullinger, MD, Clara D. Bloomfield, MD, Richard M. Stone, MD, Hartmut Döhner, MD, Christian Thiede, MD, Konstanze Dohner, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 435.
https://doi.org/10.1182/blood-2018-99-116149
Published: 2018
Journal Articles

Gemtuzumab Ozogamicin in NPM1 -Mutated Acute Myeloid Leukemia (AML): Results from the Prospective Randomized AMLSG 09-09 Phase-III Study

Richard F. Schlenk, MD, Peter Paschka, MD, Julia Krzykalla, MSc, Daniela Weber, MSc, Silke Kapp-Schwoerer, MD, Verena I. Gaidzik, MD, Claudia Leis, Walter Fiedler, MD, Thomas Kindler, MD, Thomas Schroeder, MD, Karin Mayer, MD, Michael Lübbert, Mohammed Amen Wattad, MD, Katharina S. Götze, MD, Heinz A. Horst, MD, Elisabeth Koller, MD, Gerald Wulf, MD, Jan Schleicher, MD, Martin Bentz, MD, Richard Greil, MD, Bernd Hertenstein, MD, Jürgen Krauter, MD, Uwe Martens, MD, David Nachbaur, MD, Maisun Abu Samra, MD, Michael Girschikofsky, MD, Axel Benner, Felicitas Thol, MD, Michael Heuser, MD, Arnold Ganser, MD, Konstanze Döhner, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 81.
https://doi.org/10.1182/blood-2018-99-113442
Published: 2018
Journal Articles

Assessment of Treatment Effects By Measurable Residual Disease Monitoring in NPM1 -Mutated AML Patients Randomized for Gemtuzumab-Ozogamicin (GO) within the AMLSG 09-09 Trial of the German-Austrian AML Study Group (AMLSG)

Silke Kapp-Schwoerer, MD, Daniela Weber, MSc, Andrea Corbacioglu, PhD, Verena I. Gaidzik, MD, Peter Paschka, MD, Jan Krönke, MD, Maria-Veronica Teleanu, MD, Frauke Theis, Frank G. Rücker, MD, Gudrun Göhring, MD, Brigitte Schlegelberger, MD PhD, Walter Fiedler, MD, Thomas Kindler, MD, Thomas Michael Schroeder, MD PhD, Karin Mayer, MD, Michael Lübbert, Mohammed Amen Wattad, MD, Katharina S. Götze, MD, Heinz A. Horst, MD, Elisabeth Koller, MD, Gerald Wulf, MD, Jan Schleicher, MD, Martin Bentz, MD, Jürgen Krauter, MD, Julia Krzykalla, MSc, Axel Benner, Richard F. Schlenk, MD, Felicitas Thol, MD, Michael Heuser, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 991.
https://doi.org/10.1182/blood-2018-99-114648
Published: 2018
Journal Articles

MYC Pathway Activation Is Frequently Observed in Treatment-Naive CLL and Defines a Subgroup with Particular Benefit from the Addition of Rituximab to Chemotherapy

Johannes Bloehdorn, MD, Julia Krzykalla, MSc, Billy Michael Chelliah Jebaraj, PhD, Karlheinz Holzmann, Dr. rer. nat., Jasmin Bahlo, PhD, Sandra Robrecht, PhD, Kathryn Humphrey, Michael Wenger, Eugen Tausch, MD, Christof Schneider, MD, Lars Bullinger, MD, Kirsten Fischer, MD, Michael Hallek, MD, Daniel Mertens, Axel Benner, Hartmut Döhner, MD, Stephan Stilgenbauer
Journal: Blood
Blood (2018) 132 (Supplement 1): 1866.
https://doi.org/10.1182/blood-2018-99-116937
Published: 2018
Journal Articles

Comprehensive Molecular Profiling of FLT3 -Mutated Acute Myeloid Leukemia (AML) Patients Treated within the Ratify Trial (Alliance C10603)

Nikolaus Jahn, MD, Ekaterina Panina, MD, Lars Bullinger, MD, Anna Dolnik, PhD, Julia Herzig, PhD, Tamara J. Blätte, MSc, Axel Benner, Julia Krzykalla, MSc, Insa Gathmann, Richard A. Larson, MD, Francesco Lo-Coco, MD, Sergio Amadori, MD, Thomas W Prior, MD, Joseph M. Brandwein, MD, Frederick R. Appelbaum, MD, Bruno C. Medeiros, MD, Martin S. Tallman, MD, Eva Tiecke, PhD, Celine Pallaud, PhD, Gerhard Ehninger, MD, Michael Heuser, MD, Arnold Ganser, MD, Richard M. Stone, MD, Christian Thiede, MD, Hartmut Döhner, MD, Clara D. Bloomfield, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1534.
https://doi.org/10.1182/blood-2018-99-115842
Published: 2018
Journal Articles

Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients

Sabine Kayser, MD, Maximilian Feszler, Julia Krzykalla, Matthias Schick, Thomas Hielscher, Axel Benner, Michael Kramer, Felicitas Thol, MD, Uwe Platzbecker, MD, Anthony D. Ho, MD, Gerhard Ehninger, MD, Michael Heuser, MD, Christian Thiede, MD, Christoph Röllig, MD, Alwin Krämer, MD
Journal: Blood
Blood (2016) 128 (22): 1663.
https://doi.org/10.1182/blood.V128.22.1663.1663
Published: 2016